Onconova Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update
May 11, 2022 16:05 ET
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., May 11, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”), a clinical-stage biopharmaceutical company focused on discovering and developing novel...
Onconova Therapeutics to Provide Corporate Update and Announce First Quarter Financial Results on May 11, 2022
May 04, 2022 16:05 ET
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., May 04, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”), a clinical-stage biopharmaceutical company focused on discovering and developing novel...
Onconova Therapeutics Announces Acceptance of Abstract for Publication at the ASCO Annual Meeting
April 27, 2022 10:17 ET
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., April 27, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for...
Onconova Therapeutics to Present at the Next Generation Kinase Inhibitors Summit
March 23, 2022 08:00 ET
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., March 23, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for...
Onconova Therapeutics Reports Full Year 2021 Financial Results and Provides Business Update
March 17, 2022 16:05 ET
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., March 17, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”), a clinical-stage biopharmaceutical company focused on discovering and developing novel...
Onconova Therapeutics to Provide Corporate Update and Announce Fourth Quarter and Full Year 2021 Financial Results on March 17, 2022
March 10, 2022 16:05 ET
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., March 10, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for...
Onconova Therapeutics to Present at the Guggenheim Oncology Conference
February 02, 2022 08:00 ET
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., Feb. 02, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for...
Onconova Therapeutics to Present at the H.C. Wainwright BIOCONNECT Virtual Conference
January 04, 2022 08:00 ET
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for...
Onconova Therapeutics Appoints Adar Makovski Silverstein, Ph.D., as Director, Corporate Development
December 13, 2021 08:00 ET
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for...
Onconova Therapeutics Announces the Presentation of Preliminary Clinical Data Providing Evidence of Rigosertib’s Activity in RDEB-associated Squamous Cell Carcinoma
December 02, 2021 08:00 ET
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., Dec. 02, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for...